The Bob Harrington ShowView all posts »
#54: Current state of surgical revascularization in patients with CAD with Dr Timothy GardnerJan 8, 2013 10:00 EST
The FREEDOM trial has added a wealth of data to the debate on revascularization in patients with heart disease. Dr Timothy Gardner joins the show to discuss the revascularization options, what we have learned from FREEDOM, BARI, BARI 2D, and PREVENT, ad hoc PCI, the role of the heart team, and why collaboration between interventionalist and CV surgeon is the way of the future.
Timothy Gardner MD
Professor, Thomas Jefferson University
Medical Director, Center for Heart and Vascular
Executive Director, Value Institute
Christiana Care Health System
Robert Harrington MD
Arthur L Bloomfield Professor of Medicine and Chair
Department of Medicine
Dr Gardner has served as the steering committee chair for the Cardiothoracic Clinical Research Network.
For Dr Harrington's disclosures, click here.
- SCAI releases new consensus on "ad hoc" PCI
- FREEDOM: CABG superior to PCI in diabetic patients with coronary disease
- No mortality, CV-event differences between revascularization and medical therapy in diabetics: BARI 2D